Breathe Easy Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Breathe Easy General Information

Description

Developer of therapeutic devices intended to provide better tools for clinicians and patients dealing with Cystic Fibrosis. The company's device liquefies and reduces the viscosity of the thick mucus that blocks the distribution of enzymes in the digestive system and the airflow in the lungs, allowing healthcare professionals to treat Cystic Fibrosis, a genetic condition affecting the lungs and digestive systems.

Contact Information

Website
www.breatheeasytherapeutics.com
Formerly Known As
Cf Newco
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • PO Box 106 818
  • Auckland, 1143
  • New Zealand
Primary Industry
Drug Discovery
Other Industries
Other Devices and Supplies
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • PO Box 106 818
  • Auckland, 1143
  • New Zealand

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Breathe Easy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-Mar-2021 Completed Out of Business
7. Seed Round 01-Aug-2016 Completed Clinical Trials - Phase 2
6. Grant 01-Jun-2015 Completed Clinical Trials - Phase 1
5. Equity Crowdfunding 18-May-2015 Completed Clinical Trials - Phase 1
4. Seed Round 01-May-2015 Completed Clinical Trials - Phase 1
3. Seed Round 31-Oct-2014 Completed Clinical Trials - Phase 1
2. Seed Round 01-Sep-2014 Completed Startup
1. Grant 01-Oct-2013 $4.08K Completed Startup
To view Breathe Easy’s complete valuation and funding history, request access »

Breathe Easy Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Breathe Easy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014269143-A1 Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms Inactive 23-May-2013
CA-2912552-A1 Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms Inactive 23-May-2013
EP-2999464-A1 Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms Inactive 23-May-2013
US-20160120898-A1 Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms Inactive 23-May-2013
EP-2999464-A4 Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms Inactive 23-May-2013 A61K33/02
To view Breathe Easy’s complete patent history, request access »

Ready to get started?

Request a free trial

Breathe Easy FAQs

  • When was Breathe Easy founded?

    Breathe Easy was founded in 2009.

  • Where is Breathe Easy headquartered?

    Breathe Easy is headquartered in Auckland, New Zealand.

  • What industry is Breathe Easy in?

    Breathe Easy’s primary industry is Drug Discovery.

  • Is Breathe Easy a private or public company?

    Breathe Easy is a Private company.

  • What is Breathe Easy’s current revenue?

    The current revenue for Breathe Easy is .

  • How much funding has Breathe Easy raised over time?

    Breathe Easy has raised $1.95M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »